Four-wheel-driven accelerated prevention and control of chronic pulmonary diseases in the post-epidemic era

doi:10.3969/j.issn.2096-8493.20210058

Abstract

Abstract:

Chronic pulmonary diseases are characterized by high prevalence, high disability rate, high fatality rate and high disease burden, and the population awareness rate is low, especially the lung function detection rate is lower. But with the impact of COVID-19, the comprehensive prevention and control of chronic pulmonary diseases must be accelerated in the post-epidemic era. We have the confidence to fulfill the tasks in the post-epidemic era by giving full play to the powerful power brought by the four-wheel drive of law engine, policy engine, planning engine and practice engine. At the same time, the combination of prevention and treatment, and the collaboration between medical and prevention is an effective way to solve the operational problems in the prevention and control of chronic respiratory diseases.

Key words: Pulmonary disease, chronic, Population surveillance, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Disease outbreaks

WU Jing. Four-wheel-driven accelerated prevention and control of chronic pulmonary diseases in the post-epidemic era[J]. Journal of Tuberculosis and Lung Disease , 2021, 2(3): 202-204. doi: 10.3969/j.issn.2096-8493.20210058

References 9

[1]	王临虹, 方利文, 吴静. 中国居民慢性阻塞性肺疾病监测报告(2014—2015). 北京: 人民卫生出版社, 2019.
[2]	国家统计局. 第六次全国人口普查主要数据发布[EB/OL]. [2011-04-28]. http://www.stats.gov.cn/ztjc/zdtjgz/zgrkpc/dlcrkpc/dcrkpcyw/201104/t20110428_69407.htm.
[3]	Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet, 2018, 391(10131):1706-1717. doi: 10.1016/S0140-6736(18)30841-9. doi: 10.1016/S0140-6736(18)30841-9 URL
[4]	钟南山, 曾广翘. 慢性呼吸疾病的防治策略. 中国临床保健杂志, 2020, 23(1):1-4. doi: 10.3969/J.issn.1672-6790.2020.01.001. doi: 10.3969/J.issn.1672-6790.2020.01.001
[5]	中共中央, 国务院. “健康中国2030”规划纲要. 2016-10-25.
[6]	中国健康行动推进委员会. 健康中国行动(2019—2030年). [2019-07-09]. http://www.nhc.gov.cn/wjw/index.shtml.
[7]	第十三届全国人民代表大会常务委员会. 中华人民共和国基本医疗卫生与健康促进法. 2019-12-28.
[8]	人民网. 整体谋划系统重塑全面提升织牢织密公共卫生防护网[EB/OL]. [2020-05-25]. http://www.jhsjk.people.cn/article/31721659.
[9]	中国政府网. 中华人民共和国国民经济和社会发展第十四个五年规划和2035年远景目标纲要[EB/OL]. [2021-3-12]. http://www.gov.cn/xinwen/2021-03/13/content_5592681.htm.

[1]	Zheng Jianli, Wu Yumei, Zhang Shili, Du Zixian, Li Turong, Chen Shisheng, Lin Wenge. Cost-effectiveness analysis of active tuberculosis screening among high-risk populations in Longyan City, Fujian Province [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 35-39.
[2]	Yang Yarui, Guo Xujun, Wei Wei, He Juan, Li Shengbin, Zhong Tao, Gao Wanling, Liu Shoujiang, Liu Shengyuan. Awareness and factors associated with chronic obstructive pulmonary disease among permanent residents aged ≥40 years old in Nanshan District, Shenzhen [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(6): 517-525.
[3]	Zhu Yixing, Chang De. Current status and prospects of management of chronic respiratory diseases [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(6): 567-572.
[4]	Yuan Lirong, Yang Qinglong, Li Yuling, Li Lin, Deng Shasha, Li Shuhua. Effect of computerized cognitive behavioral therapy in the management of symptom cluster in patients with chronic obstructive pulmonary disease: a randomized controlled trial [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(5): 476-483.
[5]	Wang Lin, Zhang Zinan. Current status and prospects of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(3): 191-196.
[6]	Zheng Xiaoxia, Zhu Xiaoxiao, Wu Yifan, Gu Fen. The correlation between symptom burden and quality of life in patients with chronic obstructive pulmonary disease [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(3): 207-211.
[7]	Qiu Qiaojing, Tao Yang, Shen Jiani, Xu Jiapin, Zhu Lihong, Gu Fen. Research of symptom groups of chronic obstructive pulmonary disease and their correlation with patient’s quality of life [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(3): 219-224.
[8]	Wu Shaozhu, Yu Xueying, Luo Yuanrong, Liu Yanfei, Ke Caixia. The effectiveness of multidisciplinary graded collaborative management on swallowing screening and intervention in patients with chronic obstructive pulmonary disease [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(3): 230-235.
[9]	Zhang Yidan, Gu Fen, Li Nannan. Current status and nursing research progress of long-term oxygen therapy for patients with chronic obstructive pulmonary disease [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(3): 249-253.
[10]	Qu Chunjin, Peng Jiayi, Liu Xinyi, Xiao Guanchen, Gu Fen, Li Nannan. Research progress on continuous nursing of patients with chronic obstructive pulmonary disease [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(3): 254-259.
[11]	Yan Yanfeng, Qi Wenxia, Cui Yonghui, Wei Caihong. Progress in the expression of long-stranded noncoding RNA and their role in chronic obstructive pulmonary disease [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(2): 172-178.
[12]	Peng Maocuo, Xie Jungang. Research progress on immune cells in chronic obstructive pulmonary disease complicated with cardiovascular disease [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(2): 179-185.
[13]	Fu Yiting, Liu Lei, Zhao Qian, Meng Jixian, Zhen Ziyi, Wang Yang, Li Rongmei. Analysis of risk factors and construction of risk prediction model for anemia in patients with chronic obstructive pulmonary disease [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(1): 20-27.
[14]	Dai Zhongshang, Zhong Yanjun, Chen Yan. Research progress on chronic obstructive pulmonary disease with bronchiectasis [J]. Journal of Tuberculosis and Lung Disease, 2023, 4(6): 499-505.
[15]	Meng Weiwei, Zeng Huihui, Chen Yan. Research progress in the application of peak inspiratory flow rate measurement in chronic airway diseases [J]. Journal of Tuberculosis and Lung Disease, 2023, 4(5): 391-396.